Planet Briefing

First published · Last updated

Janus Kinase Inhibitor Use in Adults Aged 65 Years and Older: A Clinical Review Across Atopic Dermatitis, Alopecia Areata, and Psoriasis

This is a clinical review article on Janus kinase inhibitor use in adults aged 65 and older, covering atopic dermatitis, alopecia areata, and psoriasis. The publisher is Elsevier BV and it was published 2026-09-01.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
4/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
6/10
Urgency
1/10

Why it matters

The review addresses medication use in an older population and may inform clinicians and patients about JAK inhibitor considerations for these conditions.

Sources

Report an issue